Paperpal Prime Logo

Clinical and Translational Allergy : Impact Factor & More

eISSN: 2045-7022pISSN: 2045-7022
JournalOpen Access

Key Metrics

CiteScore
6.8
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q2Immunology
SNIP
1.57
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical and Translational Allergy

Clinical and Translational Allergy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Article-by-article
Article Processing ChargesUSD 2760 | EUR 2500 | GBP 2200
Publication Time11
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorEuropean Academy for Allergy and Clinical Immunology
FrequencyArticle-by-article
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 11
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Clinical and Translational Allergy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical and Translational Allergy

Sustained Effectiveness of Lanadelumab in Preventing Hereditary Angioedema Attacks: The ENABLE Study
  • 6 Aug 2026
  • Clinical and Translational Allergy
Criteria for Control and Remission of Respiratory Allergic Disease With Allergen Immunotherapy: A Delphi Consensus.
  • 1 Aug 2026
  • Clinical and translational allergy
Title not available
  • 1 Aug 2026
  • Clinical and Translational Allergy
Integrated Immune, Epithelial and Lipid Pathways in NSAID-Exacerbated Respiratory Disease.
  • 1 Aug 2026
  • Clinical and translational allergy
Dupilumab Combined With House Dust Mite Allergen Immunotherapy for Atopic Dermatitis: A Systematic Review and Meta-Analysis.
  • 1 Aug 2026
  • Clinical and translational allergy
Gamma Delta T Cells in Shrimp Allergy Express a Unique Cytotoxic Cytokine Profile
  • 30 Jul 2026
  • Clinical and Translational Allergy
Sustained Effectiveness of Lanadelumab in Preventing Hereditary Angioedema Attacks: The ENABLE Study
  • 6 Aug 2026
  • Clinical and Translational Allergy
Criteria for Control and Remission of Respiratory Allergic Disease With Allergen Immunotherapy: A Delphi Consensus.
  • 1 Aug 2026
  • Clinical and translational allergy
Title not available
  • 1 Aug 2026
  • Clinical and Translational Allergy
Integrated Immune, Epithelial and Lipid Pathways in NSAID-Exacerbated Respiratory Disease.
  • 1 Aug 2026
  • Clinical and translational allergy
Dupilumab Combined With House Dust Mite Allergen Immunotherapy for Atopic Dermatitis: A Systematic Review and Meta-Analysis.
  • 1 Aug 2026
  • Clinical and translational allergy
Gamma Delta T Cells in Shrimp Allergy Express a Unique Cytotoxic Cytokine Profile
  • 30 Jul 2026
  • Clinical and Translational Allergy

FAQs on Clinical and Translational Allergy